Skip to main content

Table 1 Correlation between miR-613 expression level in PTC and clinicopathologic features

From: MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2

Clinicopathologic features Cases miR-613 expression P value
Gender
 Male 86 1.471 ± 0.188 0.415
 Female 21 1.304 ± 0.103  
Age
  ≥ 55 83 1.358 ± 0.101 0.583
  < 55 24 1.251 ± 0.207  
Tumor size
 1–2 cm 64 1.4 ± 0.145 0.656
  > 2 cm 43 1.329 ± 0.040  
Lymph node metastasis
 Yes 79 0.326 ± 0.040 0.01
 No 28 1.689 ± 0.057  
Multiplicity
 Yes 57 1.3 ± 0.127 0.513
 No 50 1.424 ± 0.135  
Extra thyroid invasion
 Yes 32 1.496 ± 0.155 0.418
 No 75 1.236 ± 0.143